Chronic Obstructive Pulmonary Disease Management Update- Pharmacist

  Price  

  Credits  2

This product is currently out of stock and unavailable.


Format
Chronic Obstructive Pulmonary Disease (COPD) is among the most common causes of illness and death in the US. It affects approximately 5% of the adult population, or almost 12 million people. COPD is the third-leading cause of death in the US; approximately 125,000 people die from the disease annually. The estimated cost of direct medical care for COPD exceeds 29 billion dollars each year. Two key COPD management guidelines were updated in 2011: the Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines and a joint guideline developed through a collaboration of the American College of Physicians (ACP), the American College of Chest Physicians (ACCP), the American Thoracic Society (ATS), and the European Respiratory Society (ERS). These guidelines address diagnostic and assessment criteria and provide drug therapy recommendations. The ACP/ACCP/ATS/ERS guidelines provide general diagnosis and management recommendations, while the GOLD guidelines provide a more step-wise approach to clinical management of COPD, and are more commonly used by clinicians. Currently available drug therapies have not been consistently shown to reduce COPD-related deaths or significantly slow disease progression (lung function decline). However, some drug therapies have been shown to decrease symptoms, improve quality-of-life, and help reduce the incidence and severity of costly COPD exacerbations, which are key aims in COPD management.

OR

Subscribe and Save. Get access to this course PLUS the Rx Resource Library!

Explore Our Subscription Options

Course Information

Target Audience

Pharm/Nurse Drug Therapy

Knowledge Level

General Overview

This activity will apply to a broad range of learning needs/pharmacy settings. It may include common disease state/therapy overivews and/or general pharmacy needs such as medication errors, immunizations, or law topics.

Learning Objectives

Course Accreditation

  • Activity Type:
    Knowledge
  • CE Broker
  • Universal Activity Number:
    Pharmacist : 0428-0000-12-011-H01-P
PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

PharmCon, Inc. is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

In order to obtain a Statement of Credit, attendees must answer poll questions where presented and complete a program evaluation. Attendees may immediately print their Statement of Credit or leave them stored on the website.

Technology Requirements

  • Hardware Requirements
    Standard Windows/Mac System
    iPad or iPhone
    Minimum screen resolution: 1024x768
    Speakers or headphones
  • Software Requirements
    Standard Windows/Mac System
    iPad or iPhone
    Minimum screen resolution: 1024x768
    Speakers or headphones
  • Network Requirements
    Broadband Internet Connection:
    T1, Hi-speed DSL or Cable
    4G cellular connection
Computer sharing is NOT permitted due to accreditation guidelines on activity monitoring. Credit is earned by one user per device.